What is Radialogica?
Radialogica operates at the intersection of health technology and oncology, specializing in the provision of advanced tools and insights designed to elevate the quality and safety of radiation treatment for cancer patients. The company's comprehensive suite of services encompasses sophisticated software solutions and robust quality management programs, catering to both clinical practice and clinical trials. By focusing on improving patient outcomes and mitigating the long-term burdens associated with cancer survivorship, Radialogica collaborates extensively with pharmaceutical companies, biotech firms, and medical device manufacturers. These partnerships are crucial for implementing effective radiation therapy quality assurance programs. With a demonstrable global footprint, Radialogica's impactful solutions have been instrumental in enhancing the treatment experience for over 1.5 million patients across more than 225 clinical sites worldwide.
How much funding has Radialogica raised?
Radialogica has raised a total of $4.7M across 4 funding rounds:
Private Equity
$1.3M
Private Equity
$2.9M
Debt
$150K
Debt
$343K
Private Equity (2013): $1.3M, investors not publicly disclosed
Private Equity (2016): $2.9M, investors not publicly disclosed
Debt (2020): $150K supported by PPP
Debt (2021): $343K featuring PPP
What's next for Radialogica?
The recent major strategic investment signifies a critical juncture for Radialogica, likely enabling accelerated expansion of its technological capabilities and market reach. This enterprise-level backing suggests a strategic focus on scaling operations, further developing its quality management software, and potentially exploring new therapeutic applications or geographical markets. The company's established collaborations with key players in the pharmaceutical and biotech sectors position it for continued growth and innovation in the competitive radiation oncology landscape. Future developments may involve deeper integration of AI and machine learning to refine treatment protocols and enhance predictive analytics for patient outcomes.
See full Radialogica company page
